Get More Information on Molecular Diagnostics Market - Request Sample Report
The Molecular Diagnostics Market Size was valued at USD 15.35 Billion in 2023, and is expected to reach USD 32.37 Billion by 2032, and grow at a CAGR of 9.07%.
The molecular diagnostics market is surging due to several key advancements and growing applications. Recent years have seen the introduction of powerful tools like shotgun metagenomic next-generation sequencing (NGS). This technology provides a comprehensive analysis, identifying a vast range of microorganisms in a single test. Additionally, the MSI Analysis System aids in detecting microsatellite instability, a crucial marker for certain cancers. Advancements in sample preparation methods, like NANOPEC, further enhance accuracy by reducing the risk of false negatives. These innovations are making molecular diagnostics more reliable and versatile, driving market adoption.
The growing significance of companion diagnostics in drug development presents another major growth factor. These tests help tailor treatment plans by identifying patients most likely to respond positively to specific therapies. This co-development approach with pharmaceuticals streamlines the drug development process, leading to safer and more effective medications reaching the market faster. The rising demand for personalized medicine and targeted therapies further fuels the need for companion diagnostics, creating significant growth opportunities within the molecular diagnostics market. The global aging population and increasing prevalence of chronic diseases like cancer and infectious diseases are creating a strong demand for advanced diagnostic tools. For instance, according to the American Cancer Society in 2023, with nearly 2 million new cancer cases reported in the US alone for 2023, there is a pressing need for rapid and reliable diagnostic tools. Molecular diagnostics offer faster, more accurate diagnoses, enabling earlier intervention and improved patient outcomes the growing need, particularly among the expanding elderly population, is a significant driver for the market.
Key Drivers:
Increasing Prevalence of Infectious Diseases and Cancer Globally
Rising Focus On R&D And Growing Funding in Molecular Diagnostics by Healthcare-Based Companies
Restraints:
Unfavourable Reimbursement Scenario for Diagnostic Companies
High Cost of Molecular Diagnostic Instruments
Opportunity:
Growing Significance of Companion Diagnostics in Drug Development Process
Increasing Growth Opportunities for Molecular Diagnostics Companies in Emerging Economies.
by Type
In the molecular diagnostics market, the instruments segment is the leading category, commanding approximately 50% of the total market share. This dominance is largely driven by significant advancements in diagnostic technology and the increasing automation of laboratory processes. Instruments such as PCR machines, next-generation sequencing (NGS) platforms, and automated liquid handling systems are integral to modern laboratories, as they enhance throughput and precision in testing.
The rising demand for accurate and rapid diagnostic solutions, particularly in areas like infectious diseases and oncology, has propelled the growth of sophisticated diagnostic instruments. Moreover, the emphasis on point-of-care testing is transforming how healthcare providers approach diagnostics, shifting the focus from traditional laboratory settings to more accessible locations, including clinics and remote care environments. This trend necessitates the development of portable and user-friendly diagnostic devices that can deliver reliable results quickly.
by Technology
Polymerase Chain Reaction (PCR) technology held 45% of the market share in 2023, as it serves as a cornerstone in the field of molecular diagnostics, fundamentally transforming how genetic material is analyzed and detected. This technique allows for the rapid and reliable amplification of specific DNA sequences, making it invaluable for a wide range of applications, including infectious disease detection, genetic testing, and forensic analysis. The versatility of PCR has led to its widespread adoption across clinical and research laboratories, significantly contributing to its leading market position.
The market dominance of PCR is further reinforced by ongoing innovations in the technology, such as real-time PCR (qPCR) and digital PCR. These advancements enhance the sensitivity and specificity of detection, enabling precise quantification of nucleic acids and allowing for the identification of low-abundance targets. Additionally, the adaptability of PCR to multiplexing techniques allows simultaneous detection of multiple pathogens or genetic variants in a single assay, streamlining testing processes. As the demand for accurate diagnostics continues to grow, especially in the wake of global health challenges, PCR technology remains pivotal in advancing molecular diagnostics and improving patient outcomes.
Get Customized Report as per Your Business Requirement - Request For Customized Report
by Application
The infectious diseases application segment in the molecular diagnostics market is currently the leading category, accounting for approximately 40% of the total market share. This prominence is primarily driven by the rising incidence of infectious pathogens and the critical need for rapid and accurate diagnostic solutions in clinical settings.
The increasing prevalence of antibiotic-resistant infections and the emergence of new infectious agents further amplify the demand for advanced diagnostic technologies. Healthcare providers require robust tools to facilitate rapid testing and accurate results, enabling prompt clinical decision-making. Moreover, technological innovations such as multiplex PCR assays and point-of-care testing devices enhance the capacity to detect multiple pathogens simultaneously, making diagnostics more efficient and accessible.
The emphasis on disease surveillance and outbreak preparedness has also prompted governments and health organizations to invest significantly in diagnostic infrastructure. As a result, the infectious diseases application segment continues to lead the market, playing a pivotal role in improving public health outcomes and responding effectively to global health crises.
North America was the dominant region with 40% of the global share in 2023. This dominance stems from a confluence of factors like a high burden of infectious and chronic diseases, prompting companies to develop innovative tests (like QIAGEN's GIST diagnostic kit), and a well-established healthcare system with strong disease awareness. However, the Asia Pacific region is poised for the fastest growth with the increased market penetration of new technologies, like the CRISPR-based point-of-care tests being developed by CrisprBits and MolBio Diagnostics in India, which is a key driver. Additionally, a large unmet need for advanced diagnostics exists in this region. The rising adoption of NGS, increased testing for critical illnesses, and growing demand for personalized medicine are all creating significant market demand. Finally, the integration of artificial intelligence and machine learning into diagnostics is another factor propelling the Asia Pacific market forward.
The players operating in the Molecular Diagnostics market are the following:
Thermo Fisher Scientific (Applied Biosystems Real-Time PCR Systems, Ion Torrent Gene Sequencing Systems, TaqMan Real-Time PCR Assays)
Roche Diagnostics (cobas 6800/8000 Systems, LightCycler 480 II Real-Time PCR System, Cobas AmpliPrep/Cobas TaqMan Assays)
Illumina (NextSeq 500 System, NovaSeq 6000 System, MiSeq System)
Agilent Technologies (SureSelect Target Enrichment Systems, SureSeq RNA Library Prep Kits, Agilent 2100 Bioanalyzer)
Qiagen (QIAcube Automated RNA Extraction System, QIAseq RNA Library Prep Kits, Rotor-Gene Q Real-Time PCR System)
Bio-Rad Laboratories (CFX Connect Real-Time PCR Detection System, S1000 Thermal Cycler, iCycler iQ Real-Time PCR Detection System)
Beckman Coulter (DxI 8000 Chemistry System, DxI 6000 Chemistry System, Allegra X-22R Centrifuge)
Seegene (Allplex COVID-19 Assay, Allplex Respiratory Panel, Allplex STI Panel)
Cepheid (GeneXpert Systems, Xpert MTB/RIF Assay, Xpert HIV-1 RNA Assay)
Abbott Laboratories (m2000 Real-Time PCR System, Alinity m Systems, RealTime PCR Assays)
Oxford Nanopore Technologies (MinION System, GridION System)
MGI Tech Co., Ltd. (DNBSEQ-T7 System, DNBSEQ-G400 System)
BGI Group (GeneSeq Sequencers, BGISeq-500 System)
NanoString Technologies (nCounter Analysis System, GeoMx Digital Spatial Profiler)
Fluidigm Corporation (C1 Single-Cell Analysis System, BioMark HD System)
Fujifilm Holdings (Lumio Molecular Imaging Systems)
PerkinElmer (VICTOR Nivo Multimode Plate Reader)
BioMérieux (NucliSENS EasyQ Real-Time PCR System)
Siemens Healthineers (Versant Molecular Diagnostics Systems)
In January 2024: Illumina joined forces with Janssen to develop a novel liquid biopsy test for detecting residual disease across various cancers. This test leverages cost-effective whole-genome sequencing to identify circulating tumor DNA (ctDNA).
| Report Attributes | Details |
| Market Size in 2023 | US$ 15.35 Billion |
| Market Size by 2032 | US$ 32.37 Billion |
| CAGR | CAGR of 9.07% From 2024 to 2032 |
| Base Year | 2023 |
| Forecast Period | 2024-2032 |
| Historical Data | 2020-2022 |
| Report Scope & Coverage | Market Size, Segments Analysis, Competitive Landscape, Regional Analysis, DROC & SWOT Analysis, Forecast Outlook |
| Key Segments | •By Technology (Polymerase Chain Reaction (PCR), Hybridization, DNA Sequencing, Microarray, Isothermal Nucleic Acid Amplification Technology (INAAT), Others) •By Application (Infectious Diseases, Oncology, Genetic Testing, Blood Screening, Others) •By Type (Instruments, Reagents, Software & Services) •By End User (Hospital, Reference Laboratories, Others) |
| Regional Analysis/Coverage | North America (USA, Canada, Mexico), Europe (Germany, UK, France, Italy, Spain, Netherlands, Rest of Europe), Asia-Pacific (Japan, South Korea, China, India, Australia, Rest of Asia-Pacific), The Middle East & Africa (Israel, UAE, South Africa, Rest of Middle East & Africa), Latin America (Brazil, Argentina, Rest of Latin America) |
| Company Profiles | Thermo Fisher Scientific, Roche Diagnostics, Illumina, Agilent Technologies, Qiagen, Bio-Rad Laboratories, Beckman Coulter, Abbott Laboratories and Others |
| Key Drivers |
• Increasing Prevalence of Infectious Diseases and Cancer Globally • Rising Focus On R&D And Growing Funding in Molecular Diagnostics by Healthcare-Based Companies |
| Market Restraints |
• Unfavourable Reimbursement Scenario for Diagnostic Companies • High Cost of Molecular Diagnostic Instruments |
Ans: The Molecular Diagnostics Market was valued at USD 15.35 Billion in 2023.
Ans: The expected CAGR of the Global Molecular Diagnostics Market during the forecast period is 9.07%
Ans: Polymerase Chain Reaction (PCR) held the largest share in the Molecular Diagnostics Market in 2023.
Ans: The Molecular Diagnostics Market will be valued at USD 32.37 Billion in 2032.
Ans: The North America led the Molecular Diagnostics Market.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
1.2 Scope (Inclusion and Exclusions)
1.3 Research Assumptions
2. Executive Summary
2.1 Market Overview
2.2 Regional Synopsis
2.3 Competitive Summary
3. Research Methodology
3.1 Top-Down Approach
3.2 Bottom-up Approach
3.3. Data Validation
3.4 Primary Interviews
4. Market Dynamics Impact Analysis
4.1 Market Driving Factors Analysis
4.1.1 Drivers
4.1.2 Restraints
4.1.3 Opportunities
4.1.4 Challenges
4.2 PESTLE Analysis
4.3 Porter’s Five Forces Model
5. Statistical Insights and Trends Reporting
5.1 Incidence and Prevalence (2023)
5.2 Prescription Trends, (2023), by Region
5.3 Device Volume, by Region (2020-2032)
5.4 Healthcare Spending, by Region, (Government, Commercial, Private, Out-of-Pocket), 2023
6. Competitive Landscape
6.1 List of Major Companies, By Region
6.2 Market Share Analysis, By Region
6.3 Product Benchmarking
6.3.1 Product specifications and features
6.3.2 Pricing
6.4 Strategic Initiatives
6.4.1 Marketing and promotional activities
6.4.2 Distribution and Supply Chain Strategies
6.4.3 Expansion plans and new product launches
6.4.4 Strategic partnerships and collaborations
6.5 Technological Advancements
6.6 Market Positioning and Branding
7. Molecular Diagnostics Market Segmentation, by Type
7.1 Chapter Overview
7.2 Reagents
7.2.1 Reagents Market Trends Analysis (2020-2032)
7.2.2 Reagents Market Size Estimates and Forecasts to 2032 (USD Billion)
7.3 Instruments
7.3.1 Instruments Market Trends Analysis (2020-2032)
7.3.2 Instruments Market Size Estimates and Forecasts to 2032 (USD Billion)
7.4 Software & Services
7.4.1 Software & Services Market Trends Analysis (2020-2032)
7.4.2 Software & Services Market Size Estimates and Forecasts to 2032 (USD Billion)
8. Molecular Diagnostics Market Segmentation, by Technology
8.1 Chapter Overview
8.2 Polymerase Chain Reaction (PCR)
8.2.1 Polymerase Chain Reaction (PCR) Market Trends Analysis (2020-2032)
8.2.2 Polymerase Chain Reaction (PCR) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.3 Hybridization
8.3.1 Hybridization Market Trends Analysis (2020-2032)
8.3.2 Hybridization Market Size Estimates and Forecasts to 2032 (USD Billion)
8.4 DNA sequencing
8.4.1 DNA sequencing Market Trends Analysis (2020-2032)
8.4.2 DNA sequencing Market Size Estimates and Forecasts to 2032 (USD Billion)
8.5 Microarray
8.5.1 Microarray Market Trends Analysis (2020-2032)
8.5.2 Microarray Market Size Estimates and Forecasts to 2032 (USD Billion)
8.6 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.6.1 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Trends Analysis (2020-2032)
8.6.2 Isothermal Nucleic Acid Amplification Technology (INAAT) Market Size Estimates and Forecasts to 2032 (USD Billion)
8.7 Others
8.7.1 Others Market Trends Analysis (2020-2032)
8.7.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
9. Molecular Diagnostics Market Segmentation, by Application
9.1 Chapter Overview
9.2 Infectious diseases
9.2.1 Infectious Diseases Market Trends Analysis (2020-2032)
9.2.2 Infectious Diseases Market Size Estimates and Forecasts to 2032 (USD Billion)
9.3 Oncology
9.3.1 Oncology Market Trends Analysis (2020-2032)
9.3.2 Oncology Market Size Estimates and Forecasts to 2032 (USD Billion)
9.4 Genetic testing
9.4.1 Genetic Testing Market Trends Analysis (2020-2032)
9.4.2 Genetic Testing Market Size Estimates and Forecasts to 2032 (USD Billion)
9.5 Blood screening
9.5.1 Blood Screening Market Trends Analysis (2020-2032)
9.5.2 Blood Screening Market Size Estimates and Forecasts to 2032 (USD Billion)
9.6 Others
9.6.1 Others Market Trends Analysis (2020-2032)
9.6.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
10. Molecular Diagnostics Market Segmentation, by End User
10.1 Chapter Overview
10.2 Hospital
10.2.1 Hospital Market Trends Analysis (2020-2032)
10.2.2 Hospital Market Size Estimates and Forecasts to 2032 (USD Billion)
10.3 Reference Laboratories
10.3.1 Reference Laboratories Market Trends Analysis (2020-2032)
10.3.2 Reference Laboratories Market Size Estimates and Forecasts to 2032 (USD Billion)
10.4 Others
10.4.1 Others Market Trends Analysis (2020-2032)
10.4.2 Others Market Size Estimates and Forecasts to 2032 (USD Billion)
11. Regional Analysis
11.1 Chapter Overview
11.2 North America
11.2.1 Trends Analysis
11.2.2 North America Molecular Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.2.3 North America Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.4 North America Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.2.5 North America Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.6 North America Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.2.7 USA
11.2.7.1 USA Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.7.2 USA Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.2.7.3 USA Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.7.4 USA Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.2.8 Canada
11.2.8.1 Canada Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.8.2 Canada Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.2.8.3 Canada Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.8.4 Canada Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.2.9 Mexico
11.2.9.1 Mexico Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.2.9.2 Mexico Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.2.9.3 Mexico Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.2.9.4 Mexico Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3 Europe
11.3.1 Eastern Europe
11.3.1.1 Trends Analysis
11.3.1.2 Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.1.3 Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.4 Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.1.5 Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.6 Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.7 Poland
11.3.1.7.1 Poland Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.7.2 Poland Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.1.7.3 Poland Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.7.4 Poland Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.8 Romania
11.3.1.8.1 Romania Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.8.2 Romania Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.1.8.3 Romania Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.8.4 Romania Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.9 Hungary
11.3.1.9.1 Hungary Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.9.2 Hungary Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.1.9.3 Hungary Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.9.4 Hungary Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.10 Turkey
11.3.1.10.1 Turkey Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.10.2 Turkey Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.1.10.3 Turkey Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.10.4 Turkey Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.1.11 Rest of Eastern Europe
11.3.1.11.1 Rest of Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.1.11.2 Rest of Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.1.11.3 Rest of Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.1.11.4 Rest of Eastern Europe Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2 Western Europe
11.3.2.1 Trends Analysis
11.3.2.2 Western Europe Molecular Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.3.2.3 Western Europe Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.4 Western Europe Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.5 Western Europe Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.6 Western Europe Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.7 Germany
11.3.2.7.1 Germany Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.7.2 Germany Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.7.3 Germany Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.7.4 Germany Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.8 France
11.3.2.8.1 France Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.8.2 France Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.8.3 France Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.8.4 France Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.9 UK
11.3.2.9.1 UK Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.9.2 UK Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.9.3 UK Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.9.4 UK Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.10 Italy
11.3.2.10.1 Italy Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.10.2 Italy Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.10.3 Italy Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.10.4 Italy Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.11 Spain
11.3.2.11.1 Spain Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.11.2 Spain Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.11.3 Spain Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.11.4 Spain Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.12 Netherlands
11.3.2.12.1 Netherlands Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.12.2 Netherlands Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.12.3 Netherlands Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.12.4 Netherlands Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.13 Switzerland
11.3.2.13.1 Switzerland Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.13.2 Switzerland Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.13.3 Switzerland Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.13.4 Switzerland Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.14 Austria
11.3.2.14.1 Austria Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.14.2 Austria Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.14.3 Austria Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.14.4 Austria Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.3.2.15 Rest of Western Europe
11.3.2.15.1 Rest of Western Europe Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.3.2.15.2 Rest of Western Europe Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.3.2.15.3 Rest of Western Europe Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.3.2.15.4 Rest of Western Europe Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4 Asia Pacific
11.4.1 Trends Analysis
11.4.2 Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.4.3 Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.4 Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.5 Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.6 Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.7 China
11.4.7.1 China Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.7.2 China Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.7.3 China Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.7.4 China Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.8 India
11.4.8.1 India Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.8.2 India Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.8.3 India Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.8.4 India Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.9 Japan
11.4.9.1 Japan Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.9.2 Japan Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.9.3 Japan Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.9.4 Japan Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.10 South Korea
11.4.10.1 South Korea Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.10.2 South Korea Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.10.3 South Korea Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.10.4 South Korea Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.11 Vietnam
11.4.11.1 Vietnam Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.11.2 Vietnam Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.11.3 Vietnam Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.11.4 Vietnam Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.12 Singapore
11.4.12.1 Singapore Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.12.2 Singapore Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.12.3 Singapore Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.12.4 Singapore Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.13 Australia
11.4.13.1 Australia Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.13.2 Australia Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.13.3 Australia Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.13.4 Australia Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.4.14 Rest of Asia Pacific
11.4.14.1 Rest of Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.4.14.2 Rest of Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.4.14.3 Rest of Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.4.14.4 Rest of Asia Pacific Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5 Middle East and Africa
11.5.1 Middle East
11.5.1.1 Trends Analysis
11.5.1.2 Middle East Molecular Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.1.3 Middle East Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.4 Middle East Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.1.5 Middle East Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.6 Middle East Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.7 UAE
11.5.1.7.1 UAE Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.7.2 UAE Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.1.7.3 UAE Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.7.4 UAE Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.8 Egypt
11.5.1.8.1 Egypt Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.8.2 Egypt Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.1.8.3 Egypt Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.8.4 Egypt Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.9 Saudi Arabia
11.5.1.9.1 Saudi Arabia Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.9.2 Saudi Arabia Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.1.9.3 Saudi Arabia Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.9.4 Saudi Arabia Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.10 Qatar
11.5.1.10.1 Qatar Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.10.2 Qatar Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.1.10.3 Qatar Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.10.4 Qatar Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.1.11 Rest of Middle East
11.5.1.11.1 Rest of Middle East Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.1.11.2 Rest of Middle East Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.1.11.3 Rest of Middle East Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.1.11.4 Rest of Middle East Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.2 Africa
11.5.2.1 Trends Analysis
11.5.2.2 Africa Molecular Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.5.2.3 Africa Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.4 Africa Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.2.5 Africa Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.6 Africa Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.2.7 South Africa
11.5.2.7.1 South Africa Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.7.2 South Africa Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.2.7.3 South Africa Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.7.4 South Africa Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.2.8 Nigeria
11.5.2.8.1 Nigeria Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.8.2 Nigeria Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.2.8.3 Nigeria Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.8.4 Nigeria Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.5.2.9 Rest of Africa
11.5.2.9.1 Rest of Africa Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.5.2.9.2 Rest of Africa Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.5.2.9.3 Rest of Africa Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.5.2.9.4 Rest of Africa Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6 Latin America
11.6.1 Trends Analysis
11.6.2 Latin America Molecular Diagnostics Market Estimates and Forecasts, by Country (2020-2032) (USD Billion)
11.6.3 Latin America Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.4 Latin America Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.6.5 Latin America Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.6 Latin America Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6.7 Brazil
11.6.7.1 Brazil Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.7.2 Brazil Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.6.7.3 Brazil Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.7.4 Brazil Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6.8 Argentina
11.6.8.1 Argentina Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.8.2 Argentina Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.6.8.3 Argentina Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.8.4 Argentina Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6.9 Colombia
11.6.9.1 Colombia Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.9.2 Colombia Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.6.9.3 Colombia Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.9.4 Colombia Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
11.6.10 Rest of Latin America
11.6.10.1 Rest of Latin America Molecular Diagnostics Market Estimates and Forecasts, by Type (2020-2032) (USD Billion)
11.6.10.2 Rest of Latin America Molecular Diagnostics Market Estimates and Forecasts, by Technology (2020-2032) (USD Billion)
11.6.10.3 Rest of Latin America Molecular Diagnostics Market Estimates and Forecasts, by Application (2020-2032) (USD Billion)
11.6.10.4 Rest of Latin America Molecular Diagnostics Market Estimates and Forecasts, by End User (2020-2032) (USD Billion)
12. Company Profiles
12.1 BD
12.1.1 Company Overview
12.1.2 Financial
12.1.3 Products/ Services Offered
12.1.4 SWOT Analysis
12.2 bioMérieux SA
12.2.1 Company Overview
12.2.2 Financial
12.2.3 Products/ Services Offered
12.2.4 SWOT Analysis
12.3 Bio-Rad Laboratories, Inc.
12.3.1 Company Overview
12.3.2 Financial
12.3.3 Products/ Services Offered
12.3.4 SWOT Analysis
12.4 Abbott
12.4.1 Company Overview
12.4.2 Financial
12.4.3 Products/ Services Offered
12.4.4 SWOT Analysis
12.5 Agilent Technologies, Inc.
12.5.1 Company Overview
12.5.2 Financial
12.5.3 Products/ Services Offered
12.5.4 SWOT Analysis
12.6 Danaher
12.6.1 Company Overview
12.6.2 Financial
12.6.3 Products/ Services Offered
12.6.4 SWOT Analysis
12.7 Hologic Inc. (Gen Probe)
12.7.1 Company Overview
12.7.2 Financial
12.7.3 Products/ Services Offered
12.7.4 SWOT Analysis
12.8 Illumina, Inc.
12.8.1 Company Overview
12.8.2 Financial
12.8.3 Products/ Services Offered
12.8.4 SWOT Analysis
12.9 Grifols, S.A.
12.9.1 Company Overview
12.9.2 Financial
12.9.3 Products/ Services Offered
12.9.4 SWOT Analysis
12.10 QIAGEN
12.10.1 Company Overview
12.10.2 Financial
12.10.3 Products/ Services Offered
12.10.4 SWOT Analysis
13. Use Cases and Best Practices
14. Conclusio
An accurate research report requires proper strategizing as well as implementation. There are multiple factors involved in the completion of good and accurate research report and selecting the best methodology to compete the research is the toughest part. Since the research reports we provide play a crucial role in any company’s decision-making process, therefore we at SNS Insider always believe that we should choose the best method which gives us results closer to reality. This allows us to reach at a stage wherein we can provide our clients best and accurate investment to output ratio.
Each report that we prepare takes a timeframe of 350-400 business hours for production. Starting from the selection of titles through a couple of in-depth brain storming session to the final QC process before uploading our titles on our website we dedicate around 350 working hours. The titles are selected based on their current market cap and the foreseen CAGR and growth.
The 5 steps process:
Step 1: Secondary Research:
Secondary Research or Desk Research is as the name suggests is a research process wherein, we collect data through the readily available information. In this process we use various paid and unpaid databases which our team has access to and gather data through the same. This includes examining of listed companies’ annual reports, Journals, SEC filling etc. Apart from this our team has access to various associations across the globe across different industries. Lastly, we have exchange relationships with various university as well as individual libraries.
Step 2: Primary Research
When we talk about primary research, it is a type of study in which the researchers collect relevant data samples directly, rather than relying on previously collected data. This type of research is focused on gaining content specific facts that can be sued to solve specific problems. Since the collected data is fresh and first hand therefore it makes the study more accurate and genuine.
We at SNS Insider have divided Primary Research into 2 parts.
Part 1 wherein we interview the KOLs of major players as well as the upcoming ones across various geographic regions. This allows us to have their view over the market scenario and acts as an important tool to come closer to the accurate market numbers. As many as 45 paid and unpaid primary interviews are taken from both the demand and supply side of the industry to make sure we land at an accurate judgement and analysis of the market.
This step involves the triangulation of data wherein our team analyses the interview transcripts, online survey responses and observation of on filed participants. The below mentioned chart should give a better understanding of the part 1 of the primary interview.
Part 2: In this part of primary research the data collected via secondary research and the part 1 of the primary research is validated with the interviews from individual consultants and subject matter experts.
Consultants are those set of people who have at least 12 years of experience and expertise within the industry whereas Subject Matter Experts are those with at least 15 years of experience behind their back within the same space. The data with the help of two main processes i.e., FGDs (Focused Group Discussions) and IDs (Individual Discussions). This gives us a 3rd party nonbiased primary view of the market scenario making it a more dependable one while collation of the data pointers.
Step 3: Data Bank Validation
Once all the information is collected via primary and secondary sources, we run that information for data validation. At our intelligence centre our research heads track a lot of information related to the market which includes the quarterly reports, the daily stock prices, and other relevant information. Our data bank server gets updated every fortnight and that is how the information which we collected using our primary and secondary information is revalidated in real time.
Step 4: QA/QC Process
After all the data collection and validation our team does a final level of quality check and quality assurance to get rid of any unwanted or undesired mistakes. This might include but not limited to getting rid of the any typos, duplication of numbers or missing of any important information. The people involved in this process include technical content writers, research heads and graphics people. Once this process is completed the title gets uploader on our platform for our clients to read it.
Step 5: Final QC/QA Process:
This is the last process and comes when the client has ordered the study. In this process a final QA/QC is done before the study is emailed to the client. Since we believe in giving our clients a good experience of our research studies, therefore, to make sure that we do not lack at our end in any way humanly possible we do a final round of quality check and then dispatch the study to the client.
Key Market Segments
By Technology
Polymerase Chain Reaction (PCR)
Hybridization
Microarray
Isothermal Nucleic Acid Amplification Technology (INAAT)
Others
By Application
Infectious diseases
Oncology
Genetic testing
Others
By Type
Instruments
Reagents
Software & Services
By End User
Hospital
Reference Laboratories
Others
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
US
Canada
Mexico
Europe
Eastern Europe
Poland
Romania
Hungary
Turkey
Rest of Eastern Europe
Western Europe
Germany
France
UK
Italy
Spain
Netherlands
Switzerland
Austria
Rest of Western Europe
Asia Pacific
China
India
Japan
South Korea
Vietnam
Singapore
Australia
Rest of Asia Pacific
Middle East & Africa
Middle East
UAE
Egypt
Saudi Arabia
Qatar
Rest of the Middle East
Africa
Nigeria
South Africa
Rest of Africa
Latin America
Brazil
Argentina
Colombia
Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
Product Analysis
Criss-Cross segment analysis (e.g. Product X Application)
Product Matrix which gives a detailed comparison of the product portfolio of each company
Geographic Analysis
Additional countries in any of the regions
Company Information
Detailed analysis and profiling of additional market players (Up to five)
The Colorectal Cancer Therapeutics Market was valued at USD 12.7 billion in 2023 and is expected to reach USD 22.0 billion by 2032 and grow at a CAGR of 6.2% over the forecast period 2024-2032.
The Cardiovascular Information System Market Size was valued at USD 1.31 billion in 2023 and is expected to reach USD 2.68 billion by 2031, and grow at a CAGR of 9.4% over the forecast period 2024-2031.
The Pharmacovigilance and Drug Safety Software Market Size was valued at USD 206.68 million in 2023 and is expected to reach USD 371.88 million by 2032 and grow at a CAGR of 6.76% over the forecast period 2024-2032.
Flash Chromatography Market was valued at USD 0.33 million in 2023, is projected to reach USD 0.50 million by 2032, growing at a CAGR of 4.6% from 2024 to 2032.
The Omega-3 Fatty Acid Market Size was valued at USD 2.5 billion in 2023 and is expected to reach USD 4.8 billion by 2032, and grow at a CAGR of 7.4% over the forecast period 2024-2032.
The Brain Computer Interface Market size was valued at USD 2.23 billion in 2023 and is expected to reach USD 8.36 billion by 2032 and grow at a CAGR of 15.81% over the forecast period of 2024-2032.
Hi! Click one of our member below to chat on Phone
© 2024 All Rights Reserved by SNS Insider Pvt Ltd
